
Lei Yao
Examiner (ID: 12775, Phone: (571)272-3112 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642 |
| Total Applications | 1328 |
| Issued Applications | 662 |
| Pending Applications | 127 |
| Abandoned Applications | 552 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8725320
[patent_doc_number] => 08404435
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-03-26
[patent_title] => 'Enigma-Mdm2 interaction and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 13/240351
[patent_app_country] => US
[patent_app_date] => 2011-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 62
[patent_no_of_words] => 11507
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13240351
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/240351 | Enigma-Mdm2 interaction and uses thereof | Sep 21, 2011 | Issued |
Array
(
[id] => 7744176
[patent_doc_number] => 20120021945
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-26
[patent_title] => 'Hypoxia-Inducible Protein 2 (HIG2), a Diagnostic Marker for Clear Cell Renal Cell Carcinoma'
[patent_app_type] => utility
[patent_app_number] => 13/224102
[patent_app_country] => US
[patent_app_date] => 2011-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 20823
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20120021945.pdf
[firstpage_image] =>[orig_patent_app_number] => 13224102
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/224102 | Hypoxia-Inducible Protein 2 (HIG2), a Diagnostic Marker for Clear Cell Renal Cell Carcinoma | Aug 31, 2011 | Abandoned |
Array
(
[id] => 8126731
[patent_doc_number] => 20120087918
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-12
[patent_title] => 'METHODS AND COMPOSITIONS FOR INHIBITING THE GROWTH OF HEMATOPOIETIC MALIGNANT CELLS'
[patent_app_type] => utility
[patent_app_number] => 13/220307
[patent_app_country] => US
[patent_app_date] => 2011-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 17847
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20120087918.pdf
[firstpage_image] =>[orig_patent_app_number] => 13220307
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/220307 | Methods and compositions for inhibiting the growth of hematopoietic malignant cells | Aug 28, 2011 | Issued |
Array
(
[id] => 11199378
[patent_doc_number] => 09429582
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-30
[patent_title] => 'Tyrosine-phosphorylated WBP2, a novel cancer target and biomarker'
[patent_app_type] => utility
[patent_app_number] => 13/819940
[patent_app_country] => US
[patent_app_date] => 2011-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 19
[patent_no_of_words] => 20954
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13819940
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/819940 | Tyrosine-phosphorylated WBP2, a novel cancer target and biomarker | Aug 24, 2011 | Issued |
Array
(
[id] => 8637089
[patent_doc_number] => 20130028893
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-31
[patent_title] => 'Therapeutic antibodies with reduced side effect'
[patent_app_type] => utility
[patent_app_number] => 13/199127
[patent_app_country] => US
[patent_app_date] => 2011-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4400
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13199127
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/199127 | Therapeutic antibodies with reduced side effect | Aug 18, 2011 | Abandoned |
Array
(
[id] => 7669494
[patent_doc_number] => 20110318763
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-29
[patent_title] => 'DETECTION OF CANCER BY ELEVATED LEVELS OF BCL-2'
[patent_app_type] => utility
[patent_app_number] => 13/205095
[patent_app_country] => US
[patent_app_date] => 2011-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 21143
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13205095
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/205095 | DETECTION OF CANCER BY ELEVATED LEVELS OF BCL-2 | Aug 7, 2011 | Abandoned |
Array
(
[id] => 8994770
[patent_doc_number] => 08518654
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-27
[patent_title] => 'Lung cancer diagnostic polypeptide, method for detecting lung cancer, and method for evaluating therapeutic effect'
[patent_app_type] => utility
[patent_app_number] => 13/197849
[patent_app_country] => US
[patent_app_date] => 2011-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 11
[patent_no_of_words] => 9365
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13197849
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/197849 | Lung cancer diagnostic polypeptide, method for detecting lung cancer, and method for evaluating therapeutic effect | Aug 3, 2011 | Issued |
Array
(
[id] => 8828668
[patent_doc_number] => 20130129713
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-23
[patent_title] => 'METHOD OF ANTIGEN LOADING FOR IMMUNOTHERAPY'
[patent_app_type] => utility
[patent_app_number] => 13/813778
[patent_app_country] => US
[patent_app_date] => 2011-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 14999
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13813778
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/813778 | METHOD OF ANTIGEN LOADING FOR IMMUNOTHERAPY | Aug 3, 2011 | |
Array
(
[id] => 7651790
[patent_doc_number] => 20110301059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-08
[patent_title] => 'Biomarkers For Human Papilloma Virus-Associated Cancers'
[patent_app_type] => utility
[patent_app_number] => 13/194624
[patent_app_country] => US
[patent_app_date] => 2011-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 15042
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0301/20110301059.pdf
[firstpage_image] =>[orig_patent_app_number] => 13194624
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/194624 | Biomarkers for human papilloma virus-associated cancers | Jul 28, 2011 | Issued |
Array
(
[id] => 9263394
[patent_doc_number] => 20130345322
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-26
[patent_title] => 'DIAGNOSTIC FOR COLORECTAL CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/809785
[patent_app_country] => US
[patent_app_date] => 2011-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 12554
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13809785
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/809785 | DIAGNOSTIC FOR COLORECTAL CANCER | Jul 13, 2011 | Abandoned |
Array
(
[id] => 7656361
[patent_doc_number] => 20110305630
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-15
[patent_title] => 'MISFOLDED PROTEINS IN CANCER TREATMENT AND DIAGNOSIS'
[patent_app_type] => utility
[patent_app_number] => 13/168129
[patent_app_country] => US
[patent_app_date] => 2011-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11885
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0305/20110305630.pdf
[firstpage_image] =>[orig_patent_app_number] => 13168129
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/168129 | MISFOLDED PROTEINS IN CANCER TREATMENT AND DIAGNOSIS | Jun 23, 2011 | Abandoned |
Array
(
[id] => 7755583
[patent_doc_number] => 20120028269
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-02
[patent_title] => 'Methods For Detection Of Gastric Cancer'
[patent_app_type] => utility
[patent_app_number] => 13/156782
[patent_app_country] => US
[patent_app_date] => 2011-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 12367
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20120028269.pdf
[firstpage_image] =>[orig_patent_app_number] => 13156782
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/156782 | Methods for detection of gastric cancer | Jun 8, 2011 | Issued |
Array
(
[id] => 8854236
[patent_doc_number] => 20130143911
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-06
[patent_title] => 'MEK1 Mutation Conferring Resistance to RAF and MEK Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/701889
[patent_app_country] => US
[patent_app_date] => 2011-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 29675
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13701889
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/701889 | MEK1 Mutation Conferring Resistance to RAF and MEK Inhibitors | Jun 8, 2011 | Abandoned |
Array
(
[id] => 7651290
[patent_doc_number] => 20110300559
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-08
[patent_title] => 'COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING CANCER AND NEURODEGENERATIVE DISEASES RELATED TO BECLIN-1'
[patent_app_type] => utility
[patent_app_number] => 13/152271
[patent_app_country] => US
[patent_app_date] => 2011-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 17731
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0300/20110300559.pdf
[firstpage_image] =>[orig_patent_app_number] => 13152271
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/152271 | Compositions and methods for diagnosing and treating cancer and neurodegenerative diseases related to Beclin-1 | Jun 2, 2011 | Issued |
Array
(
[id] => 10025052
[patent_doc_number] => 09066930
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-30
[patent_title] => 'Activin receptor-like kinase-1 compositions and methods of use'
[patent_app_type] => utility
[patent_app_number] => 13/112954
[patent_app_country] => US
[patent_app_date] => 2011-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 43
[patent_no_of_words] => 43526
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13112954
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/112954 | Activin receptor-like kinase-1 compositions and methods of use | May 19, 2011 | Issued |
Array
(
[id] => 8755567
[patent_doc_number] => 20130089872
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-11
[patent_title] => 'ANTI-HUMAN TROP-2 ANTIBODY HAVING ANTI-TUMOR ACTIVITY IN VIVO'
[patent_app_type] => utility
[patent_app_number] => 13/698201
[patent_app_country] => US
[patent_app_date] => 2011-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 34835
[patent_no_of_claims] => 68
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13698201
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/698201 | Anti-human TROP-2 antibody having anti-tumor activity in vivo | May 16, 2011 | Issued |
Array
(
[id] => 8066089
[patent_doc_number] => 20110243974
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-06
[patent_title] => 'NOVEL TUMOR ANTIGEN PROTEIN SART-3 AND TUMOR ANTIGEN PEPTIDES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/109976
[patent_app_country] => US
[patent_app_date] => 2011-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17878
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0243/20110243974.pdf
[firstpage_image] =>[orig_patent_app_number] => 13109976
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/109976 | Tumor antigen protein SART-3 and tumor antigen peptides thereof | May 16, 2011 | Issued |
Array
(
[id] => 7582661
[patent_doc_number] => 20110296544
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-01
[patent_title] => 'COLON CANCER TARGETS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/108674
[patent_app_country] => US
[patent_app_date] => 2011-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 66441
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0296/20110296544.pdf
[firstpage_image] =>[orig_patent_app_number] => 13108674
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/108674 | COLON CANCER TARGETS AND USES THEREOF | May 15, 2011 | Abandoned |
Array
(
[id] => 8814567
[patent_doc_number] => 20130115612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-09
[patent_title] => 'METHOD FOR ANALYZING MUCIN 1 HAVING SIAALPHA2-8SIAALPHA2-3GALBETA GLYCANS'
[patent_app_type] => utility
[patent_app_number] => 13/696404
[patent_app_country] => US
[patent_app_date] => 2011-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11907
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13696404
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/696404 | METHOD FOR ANALYZING MUCIN 1 HAVING SIAALPHA2-8SIAALPHA2-3GALBETA GLYCANS | May 5, 2011 | Abandoned |
Array
(
[id] => 9477174
[patent_doc_number] => 20140134637
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-15
[patent_title] => 'METHODS OF MODULATING SMYD3 FOR TREATMENT OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/092770
[patent_app_country] => US
[patent_app_date] => 2011-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 14759
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13092770
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/092770 | METHODS OF MODULATING SMYD3 FOR TREATMENT OF CANCER | Apr 21, 2011 | Abandoned |